Table 1.
Baseline characteristics of participants.
| PID | Sex | Age | ADOS-2 Level ASD |
Comorbidities | Medication |
|---|---|---|---|---|---|
| KETOA-01 | F | 8 | High | Hypoglycemia | Trazodone, Diazepam |
| KETOA-02 | M | 11 | High | ADHD, DCD | Dexmethylphenidate |
| KETOA-03 | M | 10 | Moderate | ADHD, DCD | Focalin, Melatonin |
| KETOA-04 | M | 13 | Moderate | ADHD, ID, DCD | |
| KETOA-05 | M | 10 | High | ID, eosinophilic esophagitis | |
| KETOA-06 | M | 6 | High | ADHD, ID | Clonidine, Melatonin |
| KETOA-07 | M | 4 | High | ADHD, LD | Zyrtec, Hydrazine, Methylphenidate |
| KETOA-08 | M | 3 | Moderate | ADHD, LD | |
| KETOA-09 | M | 6 | Moderate | DCD | |
| KETOA-10 | M | 7 | Moderate | ADHD, ID, DCD | Focalin |
| KETOA-11 | M | 5 | Moderate | ID, DCD, Reactive attachment disorder | Lamotrigine |
| KETOA-12 | M | 12 | High | ADHD, DCD, ID | Advair, Flonase |
| KETOA-13 | F | 3 | Moderate | ADHD, DCD | Probiotics |
| KETOA-14 | M | 10 | Moderate | ||
| KETOA-15 | M | 11 | High | ADHD, DCD, ID | Methylphenidate |